from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. Plural form of heparin.


Sorry, no etymologies found.


  • PMX-60056 is designed to reverse the anticoagulant activity of both heparin and low molecular weight heparins LMWH.

  • Explain that there has not been a rapid effective test to determine if the level of coagulation with low molecular weight heparins has been sufficient. - medical news plus CME for physicians

  • Silvain and colleagues explained that low molecular weight heparins such as enoxaparin appear to be safer and at least as effective as unfractionated heparin, but are not widely used. - medical news plus CME for physicians

  • The Pharmacor 2010 findings from the topic entitled Venous Thromboembolism reveal that the dominance that low-molecular-weight heparins have held in the venous thromboembolism drug market will be severely reduced over the next decade, following the introduction and deep market penetration of several novel oral agents.


  • Low-molecular-weight heparins such as enoxaparin are preferred for prevention of venous thromboembolism after major joint replacement.

    Clinical Cases and Images: CasesBlog

  • Enoxaparin is made up of a complex blend of low molecular weight substances (oligosaccharides) derived from heparins, and therefore requires sophisticated analytical methods on the part of the manufacturer to ensure accurate and reliable characterization, development and production.


  • Phase 1 testing and is being developed to reverse the anticoagulant activity of both heparin and low molecular weight heparins LMWH.

    PolyMedix Organizes Infectious Disease Clinical Advisory Board - Yahoo! Finance

  • In terms of their efficacy and safety profiles, practicality of use, and cost-effectiveness the low-molecular-weight heparins are at least comparable to, and offer several advantages over, other available antithrombotics in cancer patients.

    BioMed Central - Latest articles

  • Venous blood clots are serious complications that can impact patients undergoing major orthopaedic surgery due to vascular damage and reduced mobility. 6 If prophylactic measures are not taken, VTE can occur in up to 60\% of these patients. 7 Current treatments, such as vitamin K antagonists and heparins, have been the foundation of anticoagulation treatment for years.

    Health News from Medical News Today

  • PMX-60056 is a novel small-molecule drug candidate designed to block the anticoagulant action of heparin and low molecular weight heparins (LMWH), clot prevention drugs which are commonly used in a number of applications.

    Health News from Medical News Today


Log in or sign up to get involved in the conversation. It's quick and easy.